Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Peakdale extends its offering by signing collaborative agreement with computational chemistry company, Cresset

Peakdale
Posted on: 24 Oct 16

Peakdale Molecular Limited, a UK-based provider of drug discovery services to the pharmaceutical and biotech industries and part of the Concept Life Sciences Group, has signed a collaboration agreement with computational chemistry company, Cresset. By partnering with Cresset, Peakdale has further extended its integrated drug discovery offering.

Cresset delivers software and contract research services which help chemists discover, design and optimise the best small molecules for their project. Cresset’s software uses 3D molecular electrostatics and shape to shed light on the properties and behaviours of chemical structures and, crucially, to understand the key interactions which underpin biological behaviour. Whilst Cresset software allows unique insights into protein-ligand interactions, it is the expertise of the Cresset scientists in interpreting the data and deriving knowledge for future compound design that is so valuable. These services are based on the research into virtual screening technology undertaken by Cresset founder, Dr Andy Vinter.

Commenting on the partnership Dr David Bardsley, Commercial Director at Cresset said: “Global discovery organisations today work with a number of service providers to enable their research efforts. However, there is an important balance to be found between approaching a single integrated service provider and companies trying to select the best expertise for each aspect of their programmes. We are delighted to be working with Peakdale and look forward to delivering our partnership to clients across the world.”

Dr Paul Doyle, Chief Operating Officer at Peakdale Molecular continued “Cresset’s reputation and experience in science and the breadth of understanding in computational problems makes them the ideal collaborator in the fields we are working. By adding their services and importantly , expertise, to the Peakdale offering we have further broadened a key element in our integrated drug discovery offering with world leading science.”

Notes to editors:

For media information

For media information please contact:

Sarah Roberts

Vane Percy & Roberts

+44(0)1737 821890

(e) sarah@vanepercy.com

 

Sue Peffer

Cresset

+44(0)1223 858890

(e) sue@cresset-group.com

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 24/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.